On November 28, 2024, the Jiangxi Provincial Medical Security Bureau issued the "Notice on the Proposed Winning Results of the Inter-provincial Alliance Centralized Volume Procurement of Biochemical Testing Reagents such as Glycometabolism".

According to the data of the proposed winning results, a total of 155 manufacturers and 2,314 specifications were selected for this volume-based procurement. Among them, 21 projects and 42 specifications submitted by KOFA Bio were all successfully selected, and all of the capacity groups were included in Group A, becoming the focus of this centralized procurement.

In this centralized procurement, KOFA Bio stood out in the fierce market competition with its excellent product quality and significant market competitiveness. KOFA Bio will continue to strengthen its R&D capabilities, continuously optimize and expand its product lines to accurately meet the diversified needs of the market. KOFA Bio will create significant value for customers through continuous technological innovation and excellent customer service, and achieve a win-win situation for the company and society with forward-looking scientific research investment and high-quality product output!